We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Polarean Imaging Plc | LSE:POLX | London | Ordinary Share | GB00BF3DT583 | ORD GBP0.00037 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.75 | 3.70 | 3.80 | 3.75 | 3.75 | 3.75 | 257,014 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 1.03M | -13.91M | -0.0644 | -0.58 | 8.09M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/2/2024 14:57 | There are two major problems. 1) Commercial traction appears to have stalled 2) They only realistically have cash to April/May before they'd need to do a "Reneuron" and suspend shares due to paying liabilities etc... If 1) was ok 2) would follow. I'm afraid without 1) you don't get 2) and that is likely terminal for equity. | nigelpm | |
07/2/2024 14:44 | If its a difference between non existence and going concern then that can happen easy. This is now priced on worse case scenario . Helped on by negative nigels. We are just into new budget year stands to reason we start seeing purchases to new sites. We didn't get any before due to being out of budget period. So that previous period of no concern this is the time when we should get traction | moontheloon | |
07/2/2024 14:41 | It's happened on various oversold shares recently | moontheloon | |
07/2/2024 14:23 | Yep, our new CEO is proving as useful as a chocolate teapot. He has presided over a collapse in the share price from 27p to 6p since his appointment and we still await news on the inevitable fund raise, let alone sales of new polarisers or conversion of existing research units. We were told to wait for news in the new calendar year when new hospital funding would be available, well how about an update Van Jako? | henley2 | |
07/2/2024 14:14 | Nothing jumps 50-200% on funding news - forget it. That's not the market right now. | nigelpm | |
07/2/2024 14:14 | It'll be a great investment for someone - I genuinely don't think equity holders today will see anything. | nigelpm | |
07/2/2024 14:00 | Well you will be getting 50-200% higher immediately | moontheloon | |
07/2/2024 13:23 | Not until after the funding is sorted. | john henry | |
07/2/2024 13:19 | Not enough though | moontheloon | |
07/2/2024 13:18 | John Henry just purchased | moontheloon | |
07/2/2024 13:14 | nigelpm i agree its being patient and wait for the funding to play out. Ive been wrong on this short term i had expected more commercial news since the Interims. Long term imho POLX will be a excellent investment. | john henry | |
07/2/2024 08:38 | Probably because there comes a point where : 1) You can't sell or you can't sell without totally trashing the price or finding a buyer much lower down as Amati did 2) to some degree it's now a blind punt - but it may come off 3) majority of investors tend to ignore market fluctuations and stay invested | nigelpm | |
07/2/2024 07:08 | I wonder why donegal ... | moontheloon | |
07/2/2024 02:38 | Agree, have a lost interest here as waiting on funding before re-entering. Amati have reduced their holding but I'm surprised that there hasn't been a large amount of selling from the other institutions. | donegal1997 | |
06/2/2024 17:40 | It's a buy | moontheloon | |
06/2/2024 17:37 | Consider yourselves owned | moontheloon | |
06/2/2024 16:22 | Sadly, my fears later last year have turned out about right - just not enough momentum to warrant any kind of valuation - I do hope they get back on track but very bleak for equity here. | nigelpm | |
06/2/2024 15:29 | For the record I sold out a few weeks back due to the lack of commercial progress. Funding news must be a matter of weeks away.Any milestones announced won't matter a jot as a placing is right around the corner. | john henry | |
06/2/2024 13:35 | Agreed Gold. For me, we needed much more commercial news in January to have any hope of raising. | nigelpm | |
06/2/2024 13:06 | POLX 6p The recently appointed CEO along with his entire Board of Directors refuse to refer to shareholders in any communications. The chairman with Board approval looked after his own selfish interest last summer. At Christmas and the new year updates from two companies Destiny and wh ireland specifically mentioned their shareholders but POLAREAN just refuse to do that. Last months salaries to this USA board of directors and ever since the last fund raise have been paid for by shareholders. In one of the latest tweets and linkedin posts it stated that the CCO had given an update :'These discussions were followed by several Polarean presenters including: Alex Dusek, Chief Commercial Officer, who provided an update on the clinical adoption of Polarean’s products.' It is just a thought but shouldn't the Board of Directors and this CEO along with the sales director , and the marketing director and dan brague on his refining the strategy role capped at 100000$ be making such a presentation to shareholders or at the very least make it available to shareholders. The refusal to sell into the UK or even allow Philips to sell into the UK is difficult to understand | goldbutler | |
06/2/2024 11:11 | Yawn. Nigel wants a trade low. A full half a year left NN and management I'm confident they're confident | moontheloon | |
06/2/2024 10:55 | Commercialisation here has just been too slow - I fear now it's probably approaching the end game for equity. A real shame but management have likely blown it. | nigelpm | |
31/1/2024 16:53 | Just change xx to capital TT | chester9 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions